The longevity economy is the most significant market disruption of our generation. With a global value estimated at $22 trillion, the economic activity generated by people aged 50 and over now rivals the GDP of the world’s largest economies. The trend pronounces a fundamental transformation in consumer behaviour, workforce composition, and the very nature of innovation and value creation, instead of just being about more people living longer. Forward-thinking leaders must recognise and act on this opportunity.
The Scale and Growth of the Longevity Economy
The economic footprint of the longevity economy is already immense. In 2020, the 50-plus population contributed $45 trillion to global GDP, accounting for 34% of the total, three times the combined revenue of the world’s 100 highest-earning companies.
Older adults (50+) now account for 42% of total global spending, a share that is projected to rise as both the number and wealth of older adults increase. By 2040, the 50+ age group will expand by 800 million people, with most growth concentrated in developing countries in Asia.
The spending growth rate for this demographic is projected at 5.5% annually over the next decade, with those aged 65 and over experiencing the fastest growth at 6–6.5% per year.
For the first time in history, the number of people aged 50 and over has surpassed the number of children under 15 globally. The longevity market is projected to grow from $21.29 billion in 2024 to $63.0 billion by 2035, representing a compound annual growth rate (CAGR) of approximately 10%.
Anti-Ageing Technologies are Turning the Tide
Emerging technologies like senolytics, CRISPR-based gene editing, and mTOR inhibitors are extending healthspan by targeting the biological roots of ageing. At the same time, AI-driven drug discovery is compressing development cycles from years to mere months, creating first-mover advantages for innovators. This intersection of biotech and AI is not only transforming healthcare but opening entirely new revenue models for pharma, wellness, and longevity startups.
The Senior Workforce: Our Competitive Differentiator
An ageing workforce is an untapped source of stability, skill, and productivity.
- Demographic Shift and Productivity Gains
By 2030, adults over 65 will comprise 20% of the U.S. workforce, a figure that is mirrored in many developed economies. Far from being a challenge, this shift is a competitive differentiator.
Data from the 2022 Harvard Business Review shows that multigenerational teams deliver 12% higher productivity, leveraging the experience, reliability, and problem-solving skills of older workers. Older workers are not only more educated and healthier than previous generations. They are working longer, often full-time, and are more likely to be self-employed, bringing valuable experience and stability to organisations
- Enabling Technologies: Exoskeletons and Cognitive Platforms
Smart organisations are investing in enabling technologies to leverage the capabilities of the senior workforce. Exoskeletons, wearable devices that augment physical capabilities, reduce injury risk and fatigue, allowing older workers to remain productive in physically demanding roles.
These devices are already being adopted in manufacturing, logistics, and healthcare, directly addressing the challenges of an ageing workforce
Cognitive assistive platforms like BrainHQ are equally transformative. These neuroplasticity-based training tools have been shown in large-scale studies to reverse age-related cognitive decline, improve memory, attention, and decision-making, and even enhance real-world outcomes such as driving safety and independent living.
These platforms are proving to be productivity multipliers that enable older workers to excel in knowledge-intensive roles.
Executing on the Opportunity: Business Models and Revenue Streams
The longevity revolution is spawning entirely new industries and revenue architectures.
- Monetising the Longevity Economy: The convergence of healthcare innovation, fintech solutions, and workplace transformation is spawning a new generation of business models at the intersection of longevity science and workforce evolution. These include:
- Direct-to-Consumer Subscriptions: Personalised supplements, peptides, and health products marketed to older adults seeking to extend healthspan and maintain productivity.
- Premium Longevity Clinics: High-end clinics offering advanced diagnostics and personalised protocols, often as annual memberships for executives and high-net-worth individuals.
- AI-Driven Drug Discovery Platforms: Licensing of AI platforms to pharmaceutical companies, with revenue from licensing fees, milestone payments, and royalties.
- Diagnostics and At-Home Monitoring: Biomarker assays, epigenetic clocks, and wearables integrated into workplace wellness programs, with recurring revenue from testing and analytics.
- Digital Health SaaS and Cognitive Platforms: Subscription-based cognitive training and telemonitoring platforms for individuals and organisations.
- Insurance and Employer Partnerships: Longevity solutions reimbursed by insurers or offered as part of employer health programs, reducing healthcare costs and extending employee working years.
The most successful ventures combine recurring revenue, high margins, and direct impact on workforce productivity and health, positioning longevity as a core pillar of future economic growth.
Navigating Challenges: Lifespan Inequality and Regulatory Frameworks
Despite the vast opportunity, the longevity economy faces headwinds, that must be tackled:
- Health and longevity gaps tied to income, geography, and lifestyle threaten inclusivity and productivity. Bridging this divide is vital for both equity and economic growth.
- Pension, labour, and healthcare systems must evolve to support longer working lives and faster biotech approvals.
- AI-driven healthcare needs robust privacy standards and shared governance to ensure fair access to innovation.
The companies that will dominate the next decade are those positioning themselves at the intersection of longevity science and workforce evolution. This includes managing demographic change as well as monetising it.
By embracing innovation, investing in enabling technologies, and adopting inclusive workforce policies, organisations can unlock unprecedented value and secure sustainable competitive advantage. Forward-thinking leaders who act now will gain an upper hand in driving growth and innovation, while contributing to a more inclusive, resilient, and prosperous future for all generations.
Sources:
https://www.brookings.edu/articles/the-age-of-the-longevity-economy/
https://pmc.ncbi.nlm.nih.gov/articles/PMC11567261/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10017145/
https://www.pewresearch.org/social-trends/2023/12/14/the-growth-of-the-older-workforce/
https://www.cdc.gov/niosh/aging/data-research/index.html#
https://www.cfainstitute.org/insights/articles/tech-empowers-older-workers#
https://quickmarketpitch.com/blogs/news/longevity-tech-business-model
https://research2guidance.com/digital-longevity-business-models-defining-the-next-healthtech-wave/